Laboratory of Chemical Biology and State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin, 130022, P. R. China.
School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, Anhui, 230026, P. R. China.
Adv Mater. 2024 Apr;36(14):e2310063. doi: 10.1002/adma.202310063. Epub 2024 Jan 4.
Pyroptosis has garnered increasing attention in cancer immunotherapy. Moreover, increasing plasma membrane damage by reactive oxygen species (ROS) is considered an effective strategy for promoting pyroptosis. However, the current tactics for enhancing membrane rupture in pyroptosis are limited by the inherent drawbacks of ROS and the immunosuppressive tumor microenvironment. Herein, a self-adaptive pyroptosis inducer (LPZ) is designed by integrating Lactobacillus rhamnosus GG (LGG) and an enzyme-like metal-organic framework to achieve potent pyroptosis immunotherapy. LPZ can adhere to cancer cell membranes through the interaction between the pili of LGG and the mucin of cancer cells. In particular, the adaptive formula can gradually enhance the ability of nanozymes to produce ROS by creating an acidic microenvironment through anaerobic respiration. These results verify that LPZ could generate high levels of ROS both on the membrane and within cancer cells, leading to pyroptotic cell death and strong antitumor immunity. Meanwhile, LGG are eventually killed by ROS in this process to halt their respiration and prevent potential biosafety concerns. Overall, this work provides new inspiration for the design of self-adaptive nanocatalytic drugs for cancer immunotherapy.
细胞焦亡在癌症免疫治疗中受到越来越多的关注。此外,增加活性氧(ROS)对细胞膜的损伤被认为是促进细胞焦亡的有效策略。然而,目前增强细胞焦亡中膜破裂的策略受到 ROS 的固有缺陷和免疫抑制性肿瘤微环境的限制。在此,通过整合鼠李糖乳杆菌 GG(LGG)和类酶金属有机骨架设计了一种自适应细胞焦亡诱导剂(LPZ),以实现有效的细胞焦亡免疫治疗。LPZ 可以通过 LGG 的菌毛与癌细胞的粘蛋白之间的相互作用黏附在癌细胞的细胞膜上。特别是,通过厌氧呼吸产生酸性微环境,自适应配方可以逐渐增强纳米酶产生 ROS 的能力。这些结果验证了 LPZ 可以在细胞膜和癌细胞内产生高水平的 ROS,导致细胞焦亡性细胞死亡和强烈的抗肿瘤免疫。同时,LGG 最终被 ROS 杀死,从而阻止它们的呼吸并防止潜在的生物安全问题。总的来说,这项工作为癌症免疫治疗中自适应纳米催化药物的设计提供了新的思路。